Francesco Berardi

5.3k total citations
153 papers, 3.9k citations indexed

About

Francesco Berardi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Francesco Berardi has authored 153 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 59 papers in Cellular and Molecular Neuroscience and 53 papers in Organic Chemistry. Recurrent topics in Francesco Berardi's work include Pharmacological Receptor Mechanisms and Effects (79 papers), Receptor Mechanisms and Signaling (62 papers) and Drug Transport and Resistance Mechanisms (29 papers). Francesco Berardi is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (79 papers), Receptor Mechanisms and Signaling (62 papers) and Drug Transport and Resistance Mechanisms (29 papers). Francesco Berardi collaborates with scholars based in Italy, United States and Switzerland. Francesco Berardi's co-authors include Roberto Perrone, Nicola Antonio Colabufo, Mauro Niso, Marcello Leopoldo, Carmen Abate, Marialessandra Contino, Enza Lacivita, Vincenzo Tortorella, Savina Ferorelli and Carmela Inglese and has published in prestigious journals such as Journal of Medicinal Chemistry, Pharmacology & Therapeutics and Experimental Brain Research.

In The Last Decade

Francesco Berardi

150 papers receiving 3.9k citations

Peers

Countries citing papers authored by Francesco Berardi

Since Specialization

Citations

This map shows the geographic impact of Francesco Berardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Berardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Berardi more than expected).

Fields of papers citing papers by Francesco Berardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Berardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Berardi. The network helps show where Francesco Berardi may publish in the future.

Co-authorship network of co-authors of Francesco Berardi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Berardi. A scholar is included among the top collaborators of Francesco Berardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Berardi. Francesco Berardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models 2021 ·Cellular Oncology ·Mauro Niso, Joanna Kopecka, (unknown), Francesco Berardi, Chiara Riganti, Carmen Abate	15
2	Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect 2021 ·European Journal of Medicinal Chemistry ·(unknown), Philip D. Mosier, Mauro Niso, Leonardo Brunetti, Francesco Berardi, Fulvio Loiodice, Marialessandra Contino, Benjamin Delprat, Tangui Maurice, Antonio Laghezza, Carmen Abate	3
3	NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines 2020 ·Cancers ·Carlos Cantonero, Pedro J. Camello, Carmen Abate, Francesco Berardi, Ginés M. Salido, Juan A. Rosado, Pedro C. Redondo	32
4	Why PB28 Could Be a Covid 2019 Game Changer? 2020 ·ACS Medicinal Chemistry Letters ·Nicola Antonio Colabufo, Marcello Leopoldo, Savina Ferorelli, Carmen Abate, Marialessandra Contino, Maria Grazia Perrone, Mauro Niso, Roberto Perrone, Francesco Berardi	5
5	Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain–Blood Barrier and Glioblastoma Stem Cells 2019 ·Molecular Pharmaceutics ·Iris C. Salaroglio, Carmen Abate, Barbara Rolando, Luigi Battaglia, Elena Gazzano, Elena Colombino, Costanzo Costamagna, Laura Annovazzi, Marta Mellai, Francesco Berardi, Maria Teresa Capucchio, Davide Schiffer, Chiara Riganti	21
6	Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors 2017 ·European Journal of Medicinal Chemistry ·(unknown), Mauro Niso, Dirk Spitzer, Francesco Berardi, Marialessandra Contino, Chiara Riganti, William G. Hawkins, Carmen Abate	39
7	Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer 2017 ·BMC Cancer ·(unknown), John R. Hornick, Mauro Niso, Francesco Berardi, Dirk Spitzer, Carmen Abate, William G. Hawkins	38
8	Novel and Selective Fluorescent σ₂‐Receptor Ligand with a 3,4‐Dihydroisoquinolin‐1‐one Scaffold: A Tool to Study σ₂ Receptors in Living Cells 2015 ·ChemBioChem ·Mauro Niso, Chiara Riganti, (unknown), Dario Ghigo, Francesco Berardi, Carmen Abate	25
9	Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries 2015 ·Neuroscience Letters ·(unknown), Francesco Berardi, Carmen Abate, Francesca Peri	38
10	The effects of new sigma (σ) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity 2014 ·Pharmacological Reports ·G Skuza, (unknown), (unknown), Giuseppe Cassano, (unknown), Carmen Abate, Francesco Berardi	12
11	Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor 2014 ·European Journal of Medicinal Chemistry ·Hanne D. Hansen, Enza Lacivita, (unknown), Matthias M. Herth, Szabolcs Lehel, Anders Ettrup, (unknown), Agnete Dyssegaard, Paola De Giorgio, Roberto Perrone, Francesco Berardi, Nicola Antonio Colabufo, Mauro Niso, Gitte M. Knudsen, Marcello Leopoldo	23
12	Investigation of σ receptors agonist/antagonist activity through N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkyl derivatives of polymethylpiperidines 2013 ·Bioorganic & Medicinal Chemistry ·Mauro Niso, Carmen Abate, Savina Ferorelli, Giuseppe Cassano, (unknown), Roberto Perrone, Francesco Berardi	9
13	PET Radiotracers for Imaging P‐glycoprotein: The Challenge for Early Diagnosis in AD 2013 ·ChemMedChem ·Marcello Leopoldo, Marialessandra Contino, Francesco Berardi, Roberto Perrone, Nicola Antonio Colabufo	5
14	A new generation of MDR modulating agents with dual activity: P-gp inhibitor and iNOS inducer agents 2010 ·Toxicology in Vitro ·Nicola Antonio Colabufo, Marialessandra Contino, Francesco Berardi, Roberto Perrone, Maria Antonietta Panaro, Antonia Cianciulli, Vincenzo Mitolo, Amalia Azzariti, (unknown), Angelo Paradiso	9
15	Identification of a red-emitting fluorescent ligand for in vitro visualization of human serotonin 5-HT1A receptors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Enza Lacivita, (unknown), Md. Jafurulla, Roopali Saxena, Nandini Rangaraj, Amitabha Chattopadhyay, Nicola Antonio Colabufo, Francesco Berardi, Roberto Perrone, Marcello Leopoldo	13
16	Bicalutamide failure in prostate cancer treatment: Involvement of Multi Drug Resistance proteins 2008 ·European Journal of Pharmacology ·Nicola Antonio Colabufo, Vincenzo Pagliarulo, Francesco Berardi, Marialessandra Contino, Carmela Inglese, Mauro Niso, (unknown), Giancarlo Albo, Arcangelo Pagliarulo, Roberto Perrone	38
17	4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators 2008 ·Bioorganic & Medicinal Chemistry ·Nicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, Maria Grazia Perrone, Marialessandra Contino, Carmela Inglese, Mauro Niso, Roberto Perrone, Amalia Azzariti, G. Simone, (unknown)	51
18	Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: Synthesis and binding affinities for 5-HT7 and 5-HT1A receptors 2007 ·Bioorganic & Medicinal Chemistry ·Marcello Leopoldo, Enza Lacivita, Nicola Antonio Colabufo, Mauro Niso, Francesco Berardi, Roberto Perrone	9
19	Carbon-11 pb-12: an attempt to visualize the dopamine d4 receptor in the primate brain with positron emission tomography 2000 ·Nuclear Medicine and Biology ·Oliver Langer, Christer Halldin, (unknown), Johan Sandell, Carl‐Gunnar Swahn, Kjell Någren, Roberto Perrone, Francesco Berardi, Marcello Leopoldo, Lars Farde	19
20	New σ and 5-HT_1A Receptor Ligands: ω-(Tetralin-1-yl)-n-alkylamine Derivatives 1996 ·Journal of Medicinal Chemistry ·Francesco Berardi, Nicola Antonio Colabufo, Giuseppe Del Giudice, Roberto Perrone, Vincenzo Tortorella, Stefano Govoni, Laura Lucchi	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact